
ESKOMECOL
Antimicrobial, anti-inflammatory, and reparative ointment for external use
Eskomecol by Esco-Pharm is a combined, high-performance medicinal ointment specifically engineered to treat purulent wounds during the first phase of the wound healing process, actively clearing necrotic tissues, eliminating mixed microflora, and significantly reducing edema.
"Esco-Pharm" LLC, 13 Mikoyan St., Yerevan, 0035, Republic of Armenia
High osmotic activity
The macrogol base effectively binds inflammatory exudate, drawing it out from deep tissue layers into the dressing to rapidly eliminate edema.
Action in purulent environment
Chloramphenicol fully maintains its reliable antibacterial qualities even when active pus and necrotic tissue masses are present.
Deep cellular conduction
Macrogol 400 acts as a target carrier, easily penetrating deep tissues without membrane damage to deliver the antibiotic to hidden pathogens.
Accelerated tissue repair
Integrated methyluracil works to accelerate cellular regeneration, advance local tissue immunity, and support step-by-step wound healing.
ESKOMECOL
Eskomecoll by Esco-Pharm is a highly trusted, combined surgical preparation developed for intensive treatment during the first phase of the wound process. By fusing active chloramphenicol and methyluracil within a highly osmotic macrogol base, it delivers an active external treatment that clearing necrotic surfaces, neutralizes mixed microflora, and draws out deep fluid accumulations. Engineered for focused, short-term application on purulent wounds, it provides a powerful clinical solution to suppress infections and clear wound areas safely.
Patent Information
Registration certificate N 22504
Active Ingredients
full ingredients_list
complete_pharmaceutical_formulation_breakdown
indications usage
Area Of Application
Indications For Use- • Purulent wounds (including slowly healing wounds infected with mixed microflora) during the first (purulent-necrotic) phase of the wound healing process.
Method To Use
Application InstructionsExternally. Apply via saturated sterile gauze napkins to loosely fill the wound cavity. For deep purulent cavities, introduce via catheter with a syringe after pre-heating the ointment to 35–36°C. Dressings performed daily, once a day, until full wound clearance. Maximum daily dose calculated by chloramphenicol: 3 g. Use from day 1 of injury for up to 4 days.
Contraindications
When Not To Use- • Individual hypersensitivity to chloramphenicol, methyluracil, or macrogols;
- • Pediatric age under 3 years old;
- • Chronic skin conditions: psoriasis, eczema, fungal skin lesions.
Precautions
Safety Information- • Strictly avoid extended use; long therapy can induce osmotic shock in healthy cells. On days 5–7, change to tissue recovery options.
- • Extended courses mandate monitoring of the peripheral blood picture.
- • Prevent any contact with eyes.
